Revive Therapeutics Engages Pharma-Olam and Strengthens Infectious Diseases Clinical Development Team to Advance U.S. FDA Clinical Study for COVID-19

    NEXT STORY
    Gentherm Provides Update Related to COVID-19
    PREV STORY
    Exagen Inc. Reports Fourth Quarter and Full Year 2019 Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Curis to Release First Quarter 2017 Financial Results and Hold Conference Call on May 4, 2017

    LEXINGTON, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    ContraFect Announces First Quarter 2018 Financial Results

    YONKERS, N.Y. , May 10, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    CRISPR Therapeutics Provides Business Update and Reports First Quarter 2018 Financial Results

    -On track to begin CTX001 clinical study in hemoglobinopathies in 2018--On track to file ...

    author_avatar
    NASDAQ Market News